Amphotericin B Properties Analysis
Let's analyze the given statements about Amphotericin B:
- Statement 1: It is a narrow spectrum antifungal agent. This statement is incorrect. Amphotericin B is known for its broad-spectrum activity against a wide range of fungi, including yeasts and molds.
- Statement 2: It can cause nephrotoxicity. This statement is correct. Nephrotoxicity (kidney damage) is a well-documented and significant side effect associated with Amphotericin B therapy.
- Statement 3: It lacks an oral preparation. This statement is correct. Amphotericin B has very poor oral bioavailability and is primarily administered via intravenous infusion for systemic infections. Oral preparations are not typically used for systemic treatment.
- Statement 4: Its lipid formulations are less toxic. This statement is correct. Lipid formulations of Amphotericin B (such as liposomal Amphotericin B) were developed to mitigate the severe toxicity, particularly nephrotoxicity, associated with the conventional deoxycholate formulation.
Final Conclusion
Statements 2, 3, and 4 are accurate descriptions of Amphotericin B.
The correct selection consists of the accurate statements: 2, 3, and 4.